1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Athlete's Foot (Tinea Pedis)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

DelveInsight’s, “ Athlete's Foot (Tinea Pedis)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
- A snapshot of the global Market therapeutics scenario for Athlete's Foot (Tinea Pedis).
- A review of the marketed products under prescription for Athlete's Foot (Tinea Pedis), regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Athlete's Foot (Tinea Pedis) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Athlete's Foot (Tinea Pedis) drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Athlete's Foot (Tinea Pedis) drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Athlete's Foot (Tinea Pedis) drugs.
- Coverage of Athlete's Foot (Tinea Pedis) Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure from 2011-2015.

Reasons to buy
- Evaluate the marketing status and exclusivity details of Athlete's Foot (Tinea Pedis) key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Athlete's Foot (Tinea Pedis).
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to ‘Disease’.
- API intelligence over marketed drugs for Athlete's Foot (Tinea Pedis) and gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Athlete's Foot (Tinea Pedis).
- Uncovering opportunities in the rapidly growing the US markets.

Table Of Contents

Athlete's Foot (Tinea Pedis)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
- Indication Overview
- Marketed Drugs Assessment
- Marketed Details of Drugs by Application Type
- Marketed Details of Drugs (NDA) by Marketing Status
- Marketed Details of Drugs by Patent Expiration Timeline
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
- The API Manufacturers by the United States Drug Master File (US DMF) Status
- The API Manufacturers by the US DMF Status (Drug Specific)
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
- The API Manufacturers by the US DMF Status (Drug Specific)
- Drugs Market Data and Forecasted Sales Figures (2011-2015)
- Marketed Drugs Information
- Drugs Description
- Route of Synthesis
- Global Active Pharmaceutical Manufacturers
- Approval Status
- Patent and Exclusivity Details
- Company Overview
- Phase III Drugs Information
- Phase III Drugs Description
- The United States Drug Master Filings (US DMF)
- Discontinued Drugs Information

List of Tables
Athlete's Foot (Tinea Pedis) Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Athlete's Foot (Tinea Pedis) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Athlete's Foot (Tinea Pedis) Therapeutic Market, US, (Year), 2014
Athlete's Foot (Tinea Pedis) Marketed Drugs, API Manufacturers by US DMF Status, 2014
Athlete's Foot (Tinea Pedis) Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Athlete's Foot (Tinea Pedis) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Athlete's Foot (Tinea Pedis) Therapeutic Market, Global Sales (in million USD), 2014
Athlete's Foot (Tinea Pedis) Marketed Drugs, API Manufacturers, Global, 2014
Athlete's Foot (Tinea Pedis) Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Athlete's Foot (Tinea Pedis), 2014

List of Figures
Athlete's Foot (Tinea Pedis) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Athlete's Foot (Tinea Pedis) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Athlete's Foot (Tinea Pedis) Therapeutic Market, US, (Year), 2014
Athlete's Foot (Tinea Pedis) Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Athlete's Foot (Tinea Pedis) Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Athlete's Foot (Tinea Pedis) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Athlete's Foot (Tinea Pedis) Therapeutic Market, Global Sales (in million USD), 2014
Athlete's Foot (Tinea Pedis) Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Antifungal Drugs: Technologies and Global Markets

Antifungal Drugs: Technologies and Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Evaluate the effect of strategic factors such as technology-driven change and industry consolidation on the antifungal drugs market. - Investigate the current market dynamics and ...

Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014 - 2025

Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global antifungal drugs market was valued at USD 10.7 billion in 2015 and is expected to reach a value of USD 12.6 billion by 2025. The increasing incidence of fungal infections worldwide is the key ...

Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dermatophytic Onychomycosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Gastrointestinal Drug Industry in Canada

  • March 2017
    92 pages
  • Gastrointestina...  

    Health Care Pro...  

    Ambulatory Care  

  • Canada  

    North America  

View report >

The future of the Pain Relief Industry in the UK

  • February 2017
    5 pages
  • Pain Relief  

  • United Kingdom  

View report >

Antiseptics Markets

  • December 2016
    58 pages
  • Antiseptics  

    Anti-Infective  

View report >

Related Market Segments :

Antifungal
Infectious Disease

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.